The Competition and Markets Authority (CMA) has begun seeking public comments regarding the anticipated acquisition of Teleflex Incorporated's acute care and interventional urology businesses by Intersurgical AG. This move comes as the CMA starts its information-gathering process to assess the potential impact on competition in the UK.
Following this acquisition, control over Intersurgical AG is expected to be acquired by Armira Capital and TA Associates. The CMA has not yet formally launched its Phase 1 investigation into the transaction, with today's invitation to comment marking the initial step in its assessment.
Interested parties are encouraged to submit written representations concerning any competition issues related to the merger.